Buti S - Search Results

1

Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation.

Bertolotti L, Segato F, Pagnini F, Buti S, Casarin A, Celia A, Ziglioli F, Maestroni U, Pedrazzi G, Ascenti V, Martini C, Cicero C, De Filippo M. Bertolotti L, et al. Among authors: buti s. Diagnostics (Basel). 2023 Sep 26;13(19):3059. doi: 10.3390/diagnostics13193059. Diagnostics (Basel). 2023. PMID: 37835802 Free PMC article.

2

Osteoblastic progression during EGFR tyrosine kinase inhibitor therapy in mutated non-small cell lung cancer: a potential blunder.

Bersanelli M, Bini P, Rabaiotti E, Facchinetti F, De Filippo M, Bortesi B, Buti S, Tiseo M. Bersanelli M, et al. Among authors: buti s. Tumori. 2017 Jan 21;103(1):66-71. doi: 10.5301/tj.5000423. Epub 2015 Sep 19. Tumori. 2017. PMID: 26391764

3

Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma.

Bersanelli M, Gnetti L, Varotti E, Ampollini L, Carbognani P, Leonardi F, Rusca M, Campanini N, Ziglioli F, Dadomo CI, Pilato FP, Cortellini A, Rapacchi E, Caruso G, Silini EM, Maestroni U, Buti S. Bersanelli M, et al. Among authors: buti s. Immunotherapy. 2019 Jan;11(1):21-35. doi: 10.2217/imt-2018-0097. Immunotherapy. 2019. PMID: 30702014

4

Pathological nodal staging score for renal cell carcinoma: how to build reliable therapeutic choices basing on assumptions.

Bersanelli M, Buti S, Santoni M, Ziglioli F, Maestroni U. Bersanelli M, et al. Among authors: buti s. Ann Transl Med. 2019 Mar;7(Suppl 1):S54. doi: 10.21037/atm.2019.03.06. Ann Transl Med. 2019. PMID: 31032333 Free PMC article. No abstract available.

5

Immunotherapy-based combinations versus standard first-line treatment for metastatic clear cell renal cell carcinoma: a systematic review and meta-analysis.

Buti S, Petrelli F, Ghidini A, Vavassori I, Maestroni U, Bersanelli M. Buti S, et al. Clin Transl Oncol. 2020 Sep;22(9):1657-1663. doi: 10.1007/s12094-020-02292-z. Epub 2020 Jan 19. Clin Transl Oncol. 2020. PMID: 31956940

6

Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.

Gentili F, Bronico I, Maestroni U, Ziglioli F, Silini EM, Buti S, de Filippo M. Gentili F, et al. Among authors: buti s. Radiol Med. 2020 Dec;125(12):1280-1287. doi: 10.1007/s11547-020-01199-7. Epub 2020 May 8. Radiol Med. 2020. PMID: 32385827

7

Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review.

Bersanelli M, Brunelli M, Gnetti L, Maestroni U, Buti S. Bersanelli M, et al. Among authors: buti s. Ther Adv Med Oncol. 2020 May 26;12:1758835920915303. doi: 10.1177/1758835920915303. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32550862 Free PMC article. Review.

8

Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature.

Verzè M, Minari R, Gnetti L, Bordi P, Leonetti A, Cosenza A, Ferri L, Majori M, De Filippo M, Buti S, Gasparro D, Nizzoli R, Azzoni C, Bottarelli L, Squadrilli A, Mozzoni P, Tiseo M. Verzè M, et al. Among authors: buti s. Cancers (Basel). 2021 Oct 28;13(21):5403. doi: 10.3390/cancers13215403. Cancers (Basel). 2021. PMID: 34771566 Free PMC article.

9

The Role of CT Imaging in Characterization of Small Renal Masses.

Bazzocchi MV, Zilioli C, Gallone VI, Commisso C, Bertolotti L, Pagnini F, Ziglioli F, Maestroni U, Aliprandi A, Buti S, Procopio G, Ascenti G, Martini C, De Filippo M. Bazzocchi MV, et al. Among authors: buti s. Diagnostics (Basel). 2023 Jan 17;13(3):334. doi: 10.3390/diagnostics13030334. Diagnostics (Basel). 2023. PMID: 36766439 Free PMC article. Review.

10

Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario.

Mazzaschi G, Giudice GC, Corianò M, Campobasso D, Perrone F, Maffezzoli M, Testi I, Isella L, Maestroni U, Buti S. Mazzaschi G, et al. Among authors: buti s. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231159753. doi: 10.1177/15330338231159753. Technol Cancer Res Treat. 2023. PMID: 36855829 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page